WILMINGTON, MA — Charles River Laboratories International, Inc. recently announced that it is pleased to have been selected as one of 230 companies for the 2019 Bloomberg Gender-Equality Index (GEI), which distinguishes companies committed to transparency in gender reporting and advancing gender diversity. For Charles River, the GEI inclusion affirms the Company’s commitment to maintaining a positive and fulfilling work environment for all employees.
Bloomberg’s standardized reporting framework offers public companies the opportunity to disclose information on how they promote gender equality across four separate areas – company statistics, policies, community engagement and products and services. Reporting companies that score above a globally-established threshold, based on the extent of disclosures and the achievement of best-in-class statistics and policies, are included in the GEI. Still, currently only 10% of eligible companies are disclosing their workplace gender policies and practices.
“I am proud that Charles River was recognized in Bloomberg’s Gender-Equality Index,” said James C. Foster, President & Chief Executive Officer of Charles River. “In 2018, 61 percent of employees promoted and 59 percent of new hires at Charles River were women, which demonstrates our commitment to gender equality. I am personally committed to creating an environment for all employees to have a rewarding and successful career and we have significantly invested in initiatives to ensure Charles River is an employer of choice.”
“We applaud Charles River and the other 229 firms tracked by the index for their action to measure gender equality through the Bloomberg GEI framework,” added Peter T. Grauer, Chairman of Bloomberg and Founding Chairman of the U.S. 30% Club. “Charles River’s GEI inclusion is a strong indicator to its employees, investors and industry peers alike that it is leading by example to advance ongoing efforts for a truly inclusive workplace.”
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit http://www.criver.com.
(NOTE: The above press release is from Charles River Labs via BusinessWire.)
Like Wilmington Apple on Facebook. Follow Wilmington Apple on Twitter. Follow Wilmington Apple on Instagram. Subscribe to Wilmington Apple’s daily email newsletter HERE. Got a comment, question, photo, press release, or news tip? Email email@example.com.